Scheme

Tata India Pharma Healthcare Fund

Holds 42 companies worth ₹1,507 Cr in Sept 2026.

Fund house
TataThe fund house that runs this scheme.
AUM
Not reportedAMFI reports no AUM for it.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 8.0% of this scheme's NAV.
Fund manager
Rajat SrivastavaRuns it since 16 Sept 2024, as the fund house dates it.

Holdings^{(Dec 2015 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	42 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	121
	Abbott India Limited	89.8
	Healthcare Global Enterprises Limited	89.5
	Divi s Laboratories Limited	85.8
	Dr Reddy s Laboratories Limited	70.3
	Apollo Hospitals Enterprise Limited	65.9
	Rainbow Children s Medicare Limited	65.1
	Cipla	63.8
	Torrent Pharmaceuticals Limited	56.9
	Max Healthcare Institute Limited	56.1
	Lupin	47.4
	Bayer Cropscience	44.7
	Syngene International Limited	43.1
	Procter Gamble Health Limited	41.5
	Sai Life Sciences Limited	39.3
	PI Industries Ltd	39.2
	Anthem Biosciences Limited	38.9
	Pfizer	37.9
	Alkem Laboratories Limited	35.7
	FDC Limited	33.8
	Fortis Healthcare Limited	29.5
	Acutaas Chemicals Limited	29.4
	Dr Lal Path Labs Limited	26.7
	Aster DM Healthcare Limited	25.3
	Ajanta Pharmaceuticals Limited	24.6
	Natco Pharma	22.8
	Sumitomo Chemical India Limited	20.8
	Gillette India Limited	18.6
	Navin Flourine International Ltd	17.8
	IPCA Laboratories Limited	13.8
	Prasol Chemicals Limited	13.3
	Symbiotec Pharmalab Limited	13.2
	Mankind Pharma Limited	11.6
	GLAXO SMITHKLINE PHARMA	11.6
	Biocon	10.4
	Dr Agarwal s Health Care Limited	10.3
	Manipal Health Enterprises Ltd	9
	ZIM LABORATORIES LTD	8.7
	SANOFI CONSUMER HEALTHCARE	8.7
	Molbio Diagnostics Limited	8.1
	Gujarat Fluorochemicals Limited	8
	Jubilant Life Sciences	0.01

Sun Pharmaceutical Ind Ltd
Abbott India Limited

Market value of each ticked company in Tata India Pharma Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Abbott India Limited
Sept 2025	₹130 Cr	₹37.6 Cr
Oct 2025	₹127 Cr	₹53.3 Cr
Nov 2025	₹104 Cr	₹67.5 Cr
Dec 2025	₹103 Cr	₹71.9 Cr
Jan 2026	₹115 Cr	₹74.1 Cr
Feb 2026	₹126 Cr	₹72.8 Cr
Mar 2026	₹127 Cr	₹72.4 Cr
Apr 2026	₹131 Cr	₹71.1 Cr
May 2026	₹130 Cr	₹75.1 Cr
Jun 2026	₹124 Cr	₹72.4 Cr
Jul 2026	₹132 Cr	₹86.8 Cr
Aug 2026	₹132 Cr	₹85.1 Cr
Sept 2026	₹121 Cr	₹89.8 Cr

Fig. 1.Market value of each ticked company in Tata India Pharma Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	5	26.01

Mid Cap	15	33.87

Small Cap	18	36.96

Unlisted	4	2.88

Cash & others		0.28

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	6.65L	121	7.99
Abbott India Limited	Equity	Pharmaceuticals & Biotechnology	33.1K	89.8	5.94
Healthcare Global Enterprises Limited	Equity	Healthcare Services	13.4L	89.5	5.92
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	92.4K	85.8	5.68
Dr Reddy s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	5.7L	70.3	4.65
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	80.7K	65.9	4.36
Rainbow Children s Medicare Limited	Equity	Healthcare Services	4.95L	65.1	4.30
Cipla	Equity	Pharmaceuticals & Biotechnology	4.74L	63.8	4.22
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	1.19L	56.9	3.76
Max Healthcare Institute Limited	Equity	Healthcare Services	6.03L	56.1	3.71
Lupin	Equity	Pharmaceuticals & Biotechnology	2.33L	47.4	3.14
Bayer Cropscience	Equity	Fertilizers & Agrochemicals	1.23L	44.7	2.96
Syngene International Limited	Equity	Healthcare Services	11.8L	43.1	2.85
Procter Gamble Health Limited	Equity	Pharmaceuticals & Biotechnology	74.6K	41.5	2.75
Sai Life Sciences Limited	Equity	Pharmaceuticals & Biotechnology	2.58L	39.3	2.60
PI Industries Ltd	Equity	Fertilizers & Agrochemicals	1.7L	39.2	2.59
Anthem Biosciences Limited	Equity	Pharmaceuticals & Biotechnology	4.53L	38.9	2.57
Pfizer	Equity	Pharmaceuticals & Biotechnology	97.7K	37.9	2.50
Alkem Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	69.1K	35.7	2.36
FDC Limited	Equity	Pharmaceuticals & Biotechnology	9.97L	33.8	2.24
Fortis Healthcare Limited	Equity	Healthcare Services	3.83L	29.5	1.95
Acutaas Chemicals Limited	Equity	Pharmaceuticals & Biotechnology	89.8K	29.4	1.95
Dr Lal Path Labs Limited	Equity	Healthcare Services	1.34L	26.7	1.76
Aster DM Healthcare Limited	Equity	Healthcare Services	3.62L	25.3	1.67
Ajanta Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	68.1K	24.6	1.63
Natco Pharma	Equity	Pharmaceuticals & Biotechnology	2.75L	22.8	1.51
Sumitomo Chemical India Limited	Equity	Fertilizers & Agrochemicals	4.8L	20.8	1.38
Gillette India Limited	Equity	Personal Products	26.5K	18.6	1.23
Navin Flourine International Ltd	Equity	Chemicals & Petrochemicals	21.6K	17.8	1.18
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	71.5K	13.8	0.91
Prasol Chemicals Limited	Equity	Chemicals & Petrochemicals	1.58L	13.3	0.88
Symbiotec Pharmalab Limited	Equity	Pharmaceuticals & Biotechnology	1.12L	13.2	0.87
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	46.3K	11.6	0.77
GLAXO SMITHKLINE PHARMA	Equity	Pharmaceuticals & Biotechnology	41.7K	11.6	0.76
Biocon	Equity	Pharmaceuticals & Biotechnology	2.8L	10.4	0.69
Dr Agarwal s Health Care Limited	Equity	Healthcare Services	2.15L	10.3	0.68
Manipal Health Enterprises Ltd	Equity	Healthcare Services	1.27L	9	0.59
ZIM LABORATORIES LTD	Equity	Pharmaceuticals & Biotechnology	6.31L	8.7	0.58
SANOFI CONSUMER HEALTHCARE	Equity	Pharmaceuticals & Biotechnology	22.8K	8.7	0.57
Molbio Diagnostics Limited	Equity	Healthcare Equipment & Supplies	62K	8.1	0.54
Gujarat Fluorochemicals Limited	Equity	Chemicals & Petrochemicals	18.2K	8	0.53
Jubilant Life Sciences	Equity	Pharmaceuticals & Biotechnology	49	0.01	0.00

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.